Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $15.11 $17.90 Friday, 10th May 2024 ACAD stock ended at $15.25. This is 0.263% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 2.78% from a day low at $15.11 to a day high of $15.53.
90 days $15.11 $26.78
52 weeks $15.11 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Sep 16, 2016 $34.15 $34.15 $34.15 $34.15 2 274 400
Sep 15, 2016 $34.17 $34.17 $34.17 $34.17 1 355 600
Sep 14, 2016 $33.41 $33.41 $33.41 $33.41 2 253 500
Sep 13, 2016 $32.07 $32.07 $32.07 $32.07 1 158 100
Sep 12, 2016 $32.47 $32.47 $32.47 $32.47 1 463 200
Sep 09, 2016 $30.87 $30.87 $30.87 $30.87 2 017 800
Sep 08, 2016 $33.09 $33.09 $33.09 $33.09 1 770 100
Sep 07, 2016 $32.00 $32.00 $32.00 $32.00 1 978 000
Sep 06, 2016 $31.43 $31.43 $31.43 $31.43 1 886 700
Sep 02, 2016 $31.59 $31.59 $31.59 $31.59 1 524 700
Sep 01, 2016 $32.10 $32.10 $32.10 $32.10 1 366 700
Aug 31, 2016 $32.13 $32.13 $32.13 $32.13 1 263 900
Aug 30, 2016 $32.54 $32.54 $32.54 $32.54 1 362 300
Aug 29, 2016 $32.62 $32.62 $32.62 $32.62 1 480 800
Aug 26, 2016 $32.86 $32.86 $32.86 $32.86 1 453 700
Aug 25, 2016 $32.30 $32.30 $32.30 $32.30 1 898 200
Aug 24, 2016 $32.46 $32.46 $32.46 $32.46 2 320 500
Aug 23, 2016 $34.36 $34.36 $34.36 $34.36 1 237 600
Aug 22, 2016 $34.32 $34.32 $34.32 $34.32 2 008 000
Aug 19, 2016 $33.64 $33.64 $33.64 $33.64 1 349 200
Aug 18, 2016 $33.27 $33.27 $33.27 $33.27 1 349 900
Aug 17, 2016 $32.56 $32.56 $32.56 $32.56 1 299 500
Aug 16, 2016 $32.37 $32.37 $32.37 $32.37 1 990 900
Aug 15, 2016 $32.82 $32.82 $32.82 $32.82 2 310 400
Aug 12, 2016 $31.37 $31.37 $31.37 $31.37 1 107 400
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT